AI assistant
Sending…
Core Laboratories Inc. /DE/ — Director's Dealing 2025
Apr 2, 2025
32685_dirs_2025-04-02_007d35c2-a16f-486e-a38c-2b5deb340a69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2025-04-01
Reporting Person: ANASTASIO CURT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-01 | Common Stock | M | 9317 | — | Acquired | 15736 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | Restricted Shares | $0 | A | 8069 | Acquired | Common Stock (8069) | Direct | |
| 2025-04-01 | Restricted Shares | $0 | M | 9317 | Disposed | Common Stock (9317) | Direct |
Footnotes
F1: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.
F2: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.
More from Core Laboratories Inc. /DE/
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Regulatory Filings
2026
Feb 4